🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a 2-part, open-label, interventional study conducted in approximate...
Status
Completed
Location
Local Institution - 103
Start Date
2018-10-04
Trial ID
NCT03720366
Treatments Being Tested
The main purpose of this study is to evaluate the effects of multiple doses...
Status
Completed
Location
ICON Early Clinical & Bioanalytical Solutions
Start Date
2023-10-27
Trial ID
NCT06111521
Treatments Being Tested
This study is designed to evaluate the safety and pharmacokinetic interacti...
Status
Completed
Location
Covance Clinical Research Unit
Start Date
2018-06-07
Trial ID
NCT03561298
Treatments Being Tested
It is a phase 1, open-label, single-center, three-part study to assess the ...
Status
Completed
Location
Richmond Pharmacology Limited
Start Date
2020-03-13
Trial ID
NCT04268394
Treatments Being Tested
THIS STUDY IS CURRENTLY RECRUITING PATIENTS WITH ALVEOLAR SOFT PART SARCOMA...
Status
Recruiting
Location
Mayo Clinic Arizona
Start Date
2017-08-15
Trial ID
NCT03016819
This is a Phase 1, open-label, fixed-sequence, 2-part DDI study. Subjects w...
Status
Completed
Location
Site 1
Start Date
2023-01-03
Trial ID
NCT05657613
The main purpose of this study is to determine effect of orforglipron capsu...
Status
Completed
Location
Fortrea Clinical Research Unit Inc.
Start Date
2024-01-02
Trial ID
NCT06186622
Treatments Being Tested
This is a single-center, non-randomized, open-label, self-controlled, Phase...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2026-05-11
Trial ID
NCT07565441
This is a Phase 1, open-label, 3-period study to determine radiprodil's pot...
Status
Completed
Location
Nucleus Network Melbourne
Start Date
2025-05-20
Trial ID
NCT06975605
Treatments Being Tested
This study will assess safety, tolerability and pharmacokinetic (PK) of VH3...
Status
Withdrawn
Location
GSK Investigational Site
Start Date
2024-08-02
Trial ID
NCT06533280